Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jacobson

Showing results (211-220 of 2,802) with videos related to

Pageof 281
Sort By:
Leukemia & Lymphoma|February 3, 2025
T-cell neoplasias and secondary malignancies after CAR-T cell therapy: current knowledge, risk factors, and implications from CAR-T engineering strategiesKatie Maurer, Caron A Jacobson
Blood Advances|July 14, 2023
Comorbidities in DLBCL: too "Severe4" CAR-T therapy?David Qualls, Caron A Jacobson
Expert Opinion on Therapeutic Patents|June 13, 2017
Highly selective A3 adenosine receptor agonists relieve chronic neuropathic painDaniela Salvemini, Kenneth A Jacobson
Current Pharmaceutical Design|October 9, 2002
Molecular modeling as a tool to investigate molecular recognition in P2Y receptorsStefano Moro, Kenneth A Jacobson
Expert Opinion on Investigational Drugs|December 13, 2019
P<sub>2</sub>-Purinoceptors: Advances and therapeutic opportunitiesMichael Williams, Kenneth A Jacobson
American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics|November 1, 1987
Class III crowding: the extraction dilemmaM A Campbell, A Jacobson
Frontiers in Endocrinology|August 30, 2021
Purinergic Signaling in Liver PathophysiologyShanu Jain, Kenneth A Jacobson
Biomolecules|May 30, 2020
In Silico Drug Design for Purinergic GPCRs: Overview on Molecular Dynamics Applied to Adenosine and P2Y ReceptorsVeronica Salmaso, Kenneth A Jacobson
Developmental Genetics|January 1, 1988
Post-transcriptional regulation of ribosomal protein gene expression during development in Dictyostelium discoideumL F Steel, A Jacobson
Cardiology Clinics|July 12, 2021
Dyslipidemia in Patients with Kidney DiseaseAneesha Thobani, Terry A Jacobson
Pageof 281

Showing results (211-220 of 2,802) with videos related to

Sort By:
Pageof 281
Leukemia & Lymphoma|February 3, 2025
T-cell neoplasias and secondary malignancies after CAR-T cell therapy: current knowledge, risk factors, and implications from CAR-T engineering strategiesKatie Maurer, Caron A Jacobson
Blood Advances|July 14, 2023
Comorbidities in DLBCL: too "Severe4" CAR-T therapy?David Qualls, Caron A Jacobson
Expert Opinion on Therapeutic Patents|June 13, 2017
Highly selective A3 adenosine receptor agonists relieve chronic neuropathic painDaniela Salvemini, Kenneth A Jacobson
Current Pharmaceutical Design|October 9, 2002
Molecular modeling as a tool to investigate molecular recognition in P2Y receptorsStefano Moro, Kenneth A Jacobson
Expert Opinion on Investigational Drugs|December 13, 2019
P<sub>2</sub>-Purinoceptors: Advances and therapeutic opportunitiesMichael Williams, Kenneth A Jacobson
American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics|November 1, 1987
Class III crowding: the extraction dilemmaM A Campbell, A Jacobson
Frontiers in Endocrinology|August 30, 2021
Purinergic Signaling in Liver PathophysiologyShanu Jain, Kenneth A Jacobson
Biomolecules|May 30, 2020
In Silico Drug Design for Purinergic GPCRs: Overview on Molecular Dynamics Applied to Adenosine and P2Y ReceptorsVeronica Salmaso, Kenneth A Jacobson
Developmental Genetics|January 1, 1988
Post-transcriptional regulation of ribosomal protein gene expression during development in Dictyostelium discoideumL F Steel, A Jacobson
Cardiology Clinics|July 12, 2021
Dyslipidemia in Patients with Kidney DiseaseAneesha Thobani, Terry A Jacobson
Pageof 281